SOLENO THERAPEUTICS INC— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$564M
↑+70.4% +$233Mvs FY2024
Total Liabilities
$114M
↑+32.4% +$28Mvs FY2024
Equity
$450M
↑+83.6% +$205Mvs FY2024
Cash
$70M
↓-20.3% -$18Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $564M | $331M |
| Current Assets | $356M | $294M |
| Cash | $70M | $88M |
| ST Investments | $235M | $204M |
| Receivables | $28M | $0 |
| Inventory | $15M | $0 |
| Other Current | $7M | $2M |
| Non-Current Assets | $208M | $37M |
| PPE | $185K | $186K |
| Goodwill | $0 | $0 |
| Intangibles | $5M | $7M |
| Investments | $201M | $27M |
| Other Non-Current | $2M | $3M |
| Total Liab+Eq | $564M | $331M |
| Current Liab. | $61M | $19M |
| Accounts Payable | $12M | $9M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $49M | $10M |
| Non-Current Liab. | $52M | $67M |
| Long-Term Debt | $50M | $50M |
| Other LT Liab. | $2M | $17M |
| Equity | $450M | $245M |
| Retained Earnings | $431M | $452M |
| Other Equity | $19M | $0 |
QuarterCharts · SEC EDGAR data · SLNO · Comparing FY2025 vs FY2024